Related references
Note: Only part of the references are listed.Phosphorylation at S2053 in Murine (S2056 in Human) DNA-PKcs Is Dispensable for Lymphocyte Development and Class Switch Recombination
Wenxia Jiang et al.
JOURNAL OF IMMUNOLOGY (2019)
PARP Inhibition Combined With Thoracic Irradiation Exacerbates Esophageal and Skin Toxicity in C57BL6 Mice
Luiza Madia Lourenco et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts
Cindy R. Timme et al.
MOLECULAR CANCER THERAPEUTICS (2018)
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells
Atif J. Khan et al.
Oncotarget (2018)
Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation
Carmen Klein et al.
RADIATION ONCOLOGY (2017)
The role of PI3Kα isoform in cardioprotection
Xavier Rossello et al.
BASIC RESEARCH IN CARDIOLOGY (2017)
Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality
Yanyan Jiang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Laura F. Ogle et al.
JOURNAL OF HEPATOLOGY (2016)
Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation-what to do?
Morton J. Cowan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
DNA-PK-A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival
Liam Cornell et al.
CLINICAL CANCER RESEARCH (2015)
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
J. Murray et al.
BRITISH JOURNAL OF CANCER (2014)
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2014)
Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis
Zachary D. Nagel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers
Tarek M. A. Abdel-Fatah et al.
BBA CLINICAL (2014)
Role of Type II Pneumocyte Senescence in Radiation-Induced Lung Fibrosis
Deborah E. Citrin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
I. M. Pires et al.
BRITISH JOURNAL OF CANCER (2012)
Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K
Joanne M. Munck et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Embolization of hepatocellular carcinoma with drug-eluting beads: Doxorubicin tissue concentration and distribution in patient liver explants
Julien Namur et al.
JOURNAL OF HEPATOLOGY (2011)
DNA-Dependent Protein Kinase and Ataxia Telangiectasia Mutated (ATM) Promote Cell Survival in Response to NK314, a Topoisomerase IIα Inhibitor
Lei Guo et al.
MOLECULAR PHARMACOLOGY (2011)
Guidelines for the welfare and use of animals in cancer research
P. Workman et al.
BRITISH JOURNAL OF CANCER (2010)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
The DNA-dependent protein kinase (DNA-PK) More than just a case of making ends meet?
Richard Hill et al.
CELL CYCLE (2010)
Loco-Regional Treatment of Hepatocellular Carcinoma
Riccardo Lencioni
HEPATOLOGY (2010)
Inhibition of Poly (ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
Rachel A. Daniel et al.
CLINICAL CANCER RESEARCH (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Standardized quantification of pulmonary fibrosis in histological samples
Ralf-Harto Huebner et al.
BIOTECHNIQUES (2008)
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia
Elaine Willmore et al.
CLINICAL CANCER RESEARCH (2008)
The catalytic subunit of DNA-dependent protein kinase regulates proliferation, telomere length, and genomic stability in human somatic cells
Brian L. Ruis et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks
Naoya Uematsu et al.
JOURNAL OF CELL BIOLOGY (2007)
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
Yan Zhao et al.
CANCER RESEARCH (2006)
Autophosphorylation of DNA-dependent protein kinase regulates DNA end processing and may also alter double-strand break repair pathway choice
XP Cui et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks
BPC Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The life and death of DNA-PK
SJ Collis et al.
ONCOGENE (2005)
Phosphorylation and regulation of DNA ligase IV stability by DNA-dependent protein kinase
YG Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries
JJJ Leahy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
I Hickson et al.
CANCER RESEARCH (2004)
A pathway of double-strand break rejoining dependent upon ATM, artemis, and proteins locating to γ-H2AX foci
E Riballo et al.
MOLECULAR CELL (2004)
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
E Willmore et al.
BLOOD (2004)
Pathways of DNA double-strand break repair during the mammalian cell cycle
K Rothkamm et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Molecular views of recombination proteins and their control
SC West
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Share Paper
